
Werner syndrome RecQ helicase-IN-1
CAS No. 2869954-34-5
Werner syndrome RecQ helicase-IN-1( —— )
Catalog No. M36443 CAS No. 2869954-34-5
Werner syndrome RecQ helicase-IN-1 is a potent Werne r syndrome RecQ DNA deconjugase (WRN) inhibitor that can be used to study cancers such as colon and stomach cancer.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
2MG | 84 | Get Quote |
![]() ![]() |
5MG | 121 | Get Quote |
![]() ![]() |
10MG | 177 | Get Quote |
![]() ![]() |
25MG | 287 | Get Quote |
![]() ![]() |
50MG | 486 | Get Quote |
![]() ![]() |
100MG | 761 | Get Quote |
![]() ![]() |
500MG | 1701 | Get Quote |
![]() ![]() |
1G | Get Quote | Get Quote |
![]() ![]() |
Biological Information
-
Product NameWerner syndrome RecQ helicase-IN-1
-
NoteResearch use only, not for human use.
-
Brief DescriptionWerner syndrome RecQ helicase-IN-1 is a potent Werne r syndrome RecQ DNA deconjugase (WRN) inhibitor that can be used to study cancers such as colon and stomach cancer.
-
DescriptionWerner syndrome RecQ helicase-IN-1 (example 42) is a potent Werner syndrome RecQ DNA helicase enzyme (WRN) inhibitor and can be used in cancer research.
-
In VitroWerner syndrome RecQ helicase-IN-1 (example 42) has an IC50 value of 100 nM for WRN ATPase and GI50 values of 50 nM and >10 μM for SW48 and DLD1 WRN-KO cell lines, respectively.
-
In Vivo——
-
Synonyms——
-
PathwayCell Cycle/DNA Damage
-
TargetDNA/RNA Synthesis
-
RecptorDNA/RNA Synthesis
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2869954-34-5
-
Formula Weight702.08
-
Molecular FormulaC31H31ClF3N9O5
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 100 mg/mL (142.43 mM; Ultrasonic )
-
SMILESC(C(NC1=C(Cl)C=C(C(F)(F)F)C=C1)=O)N2C=3N(C(=O)C(=C2CC)N4CCN(C(=O)C=5C(O)=C(C)N=CN5)CC4)N=C(N3)C=6CCOCC6
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference



-
Gallium maltolate
Gallium maltolate is a ribonucleoside-diphosphate reductase inhibitor.
-
Trifluridine
Trifluorothymidine (TFT) and is an inhibitor of thymidine phosphorylase.
-
HALOFUGINONE LACTATE
HALOFUGINONE LACTATE is a halogenated derivative of febrifugine, a natural quinazolinone-containing compound found in the Chinese herb D. febrifuga.Halofuginone inhibits prolyl-tRNA synthetase in an ATP-dependent manner with a Ki of 18.3 nM.?Halofuginone is a specific inhibitor of type-I collagen synthesis and attenuates osteoarthritis (OA) by inhibition of TGF-β activityhalofuginone (HF), a widely studied derivative of febrifugine, inhibits the development of T(H)17-driven autoimmunity in a mouse model of multiple sclerosis by activating the amino acid response (AAR) pathway.?HF binds glutamyl-prolyl-tRNA synthetase (EPRS), inhibiting prolyl-tRNA synthetase activity;?this inhibition is reversed by the addition of exogenous proline or EPRS.